{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,7]],"date-time":"2026-09-07T22:08:32Z","timestamp":1788818912732,"version":"build-2803163510"},"reference-count":21,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,9,8]],"date-time":"2026-09-08T00:00:00Z","timestamp":1788825600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,9,8]],"date-time":"2026-09-08T00:00:00Z","timestamp":1788825600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["matern health, neonatol and perinatol"],"DOI":"10.1186\/s40748-026-00296-1","type":"journal-article","created":{"date-parts":[[2026,9,7]],"date-time":"2026-09-07T22:03:08Z","timestamp":1788818588000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Comparison of microdrop administration using a bottle adapter of 2.5% phenylephrine and 0.8% tropicamide with standard drop for ROP examination: a randomized controlled noninferiority trial"],"prefix":"10.1186","volume":"12","author":[{"ORCID":"https:\/\/orcid.org\/0009-0002-9850-1147","authenticated-orcid":false,"given":"Vivetha","family":"Elango","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Narayanan","family":"E.","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Muthukumaran","family":"N.","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,9,8]]},"reference":[{"issue":"1","key":"296_CR1","doi-asserted-by":"publisher","first-page":"e000448","DOI":"10.1136\/bmjpo-2019-000448","volume":"3","author":"LJ Kremer","year":"2019","unstructured":"Kremer LJ, Reith DM, Medlicott N, Broadbent R. Systematic review of mydriatics used for screening of retinopathy in premature infants. BMJ Paediatr Open. 2019;3(1):e000448.","journal-title":"BMJ Paediatr Open"},{"issue":"6","key":"296_CR2","doi-asserted-by":"publisher","first-page":"e163","DOI":"10.1542\/neo.4-6-e163","volume":"4","author":"TE Young","year":"2003","unstructured":"Young TE. Topical mydriatics: the adverse effects of screening examinations for retinopathy of prematurity. NeoReviews. 2003;4(6):e163\u20136.","journal-title":"NeoReviews"},{"issue":"10","key":"296_CR3","doi-asserted-by":"publisher","first-page":"1364","DOI":"10.1001\/archopht.1987.01060100066027","volume":"105","author":"MG Lynch","year":"1987","unstructured":"Lynch MG, Brown RH, Goode SM, Schoenwald RD, Chien S. Reduction of phenylephrine drop size in infants achieves equal dilation with decreased systemic absorption. Arch Ophthalmol. 1987;105(10):1364\u20135.","journal-title":"Arch Ophthalmol"},{"issue":"6","key":"296_CR4","doi-asserted-by":"publisher","first-page":"364","DOI":"10.1136\/bjo.77.6.364","volume":"77","author":"S Wheatcroft","year":"1993","unstructured":"Wheatcroft S, Sharma A, McAllister J. Reduction in mydriatic drop size in premature infants. Br J Ophthalmol. 1993;77(6):364\u20135.","journal-title":"Br J Ophthalmol"},{"issue":"2","key":"296_CR5","doi-asserted-by":"publisher","first-page":"178","DOI":"10.1111\/j.1600-0420.1997.tb00119.x","volume":"75","author":"O Elibol","year":"1997","unstructured":"Elibol O, Alcelik T, Yuksel N, Caglar Y. The influence of drop size of cyclopentolate, phenylephrine and tropicamide on pupil dilatation and systemic side effects in infants. Acta Ophthalmol Scand. 1997;75(2):178\u201380.","journal-title":"Acta Ophthalmol Scand"},{"issue":"2","key":"296_CR6","doi-asserted-by":"publisher","first-page":"165","DOI":"10.1111\/aos.13175","volume":"95","author":"AL Lux","year":"2017","unstructured":"Lux AL, Degoumois A, Barjol A, Mouriaux F, Denion E. Combination of 5% phenylephrine and 0.5% tropicamide eyedrops for pupil dilation in neonates is twice as effective as 0.5% tropicamide eyedrops alone. Acta Ophthalmol. 2017;95(2):165\u20139.","journal-title":"Acta Ophthalmol"},{"issue":"6","key":"296_CR7","doi-asserted-by":"publisher","first-page":"603","DOI":"10.1136\/archdischild-2019-318733","volume":"106","author":"LJ Kremer","year":"2021","unstructured":"Kremer LJ, Broadbent R, Medlicott N, Sime MJ, McCaffrey F, Reith DM. Randomized controlled pilot trial comparing low dose and very low-dose microdrop administration of phenylephrine and cyclopentolate for retinopathy of prematurity eye examinations in neonates. Arch Dis Child Fetal Neonatal Ed. 2021;106(6):603\u20138.","journal-title":"Arch Dis Child Fetal Neonatal Ed"},{"issue":"2","key":"296_CR8","doi-asserted-by":"publisher","first-page":"110","DOI":"10.1001\/jamaophthalmol.2024.5462","volume":"143","author":"AK Seliniotaki","year":"2025","unstructured":"Seliniotaki AK, Lithoxopoulou M, Virgiliou C, et al. Efficacy and safety of mydriatic microdrops for retinopathy of prematurity screening: the MyMiROPS randomized clinical trial. JAMA Ophthalmol. 2025;143(2):110\u20136. https:\/\/doi.org\/10.1001\/jamaophthalmol.2024.5462.","journal-title":"JAMA Ophthalmol"},{"issue":"1\u20132","key":"296_CR9","doi-asserted-by":"publisher","first-page":"63","DOI":"10.1177\/0973217920934397","volume":"34","author":"P Chandra","year":"2020","unstructured":"Chandra P, Chawla D, Deorari AK, Dogra MR, Jalali S, Kumar P, et al. Screening and management of retinopathy of prematurity. J Neonatol. 2020;34(1\u20132):63\u201382. https:\/\/doi.org\/10.1177\/0973217920934397.","journal-title":"J Neonatol"},{"issue":"1","key":"296_CR10","doi-asserted-by":"publisher","first-page":"415","DOI":"10.1186\/s12887-019-1757-3","volume":"19","author":"A Alpay","year":"2019","unstructured":"Alpay A, Canturk Ugurbas S, Aydemir C. Efficiency and safety of phenylephrine and tropicamide used in premature retinopathy: a prospective observational study. BMC Pediatr. 2019;19(1):415.","journal-title":"BMC Pediatr"},{"issue":"1","key":"296_CR11","doi-asserted-by":"publisher","first-page":"e20153757","DOI":"10.1542\/peds.2015-3757","volume":"137","author":"EC Eichenwald","year":"2016","unstructured":"Eichenwald EC. Apnea of prematurity. Pediatrics. 2016;137(1):e20153757.","journal-title":"Pediatrics"},{"key":"296_CR12","first-page":"CD012937","volume":"2019","author":"T Abiramalatha","year":"2019","unstructured":"Abiramalatha T, Thanigainathan S, Ninan B. Routine monitoring of gastric residual for prevention of necrotizing enterocolitis in preterm infants. Cochrane Database Syst Rev. 2019;2019:CD012937.","journal-title":"Cochrane Database Syst Rev"},{"issue":"1","key":"296_CR13","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1097\/00000658-197801000-00001","volume":"187","author":"MJ Bell","year":"1978","unstructured":"Bell MJ, Ternberg JL, Feigin RD, Keating JP, Marshall R, Barton L, et al. Neonatal necrotizing enterocolitis: therapeutic decisions based upon clinical staging. Ann Surg. 1978;187(1):1\u20137.","journal-title":"Ann Surg"},{"issue":"4","key":"296_CR14","doi-asserted-by":"publisher","first-page":"332","DOI":"10.1007\/s004670050771","volume":"14","author":"JT Flynn","year":"2000","unstructured":"Flynn JT. Neonatal hypertension: diagnosis and management. Pediatr Nephrol. 2000;14(4):332\u201341.","journal-title":"Pediatr Nephrol"},{"issue":"1","key":"296_CR15","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1007\/s00467-010-1755-z","volume":"27","author":"JM Dionne","year":"2012","unstructured":"Dionne JM, Abitbol CL, Flynn JT. Hypertension in infancy: diagnosis, management and outcome. Pediatr Nephrol. 2012;27(1):17\u201332.","journal-title":"Pediatr Nephrol"},{"key":"296_CR16","doi-asserted-by":"publisher","DOI":"10.1002\/9781118793916","volume-title":"Clinical trials: a practical approach","author":"SJ Pocock","year":"2013","unstructured":"Pocock SJ. Clinical trials: a practical approach. Chichester: Wiley; 2013."},{"issue":"8","key":"296_CR17","doi-asserted-by":"publisher","first-page":"267","DOI":"10.1016\/j.bjae.2019.03.004","volume":"19","author":"J Walker","year":"2019","unstructured":"Walker J. Noninferiority statistics and equivalence studies. BJA Educ. 2019;19(8):267\u201371.","journal-title":"BJA Educ"},{"issue":"24","key":"296_CR18","doi-asserted-by":"publisher","first-page":"2594","DOI":"10.1001\/jama.2012.87802","volume":"308","author":"G Piaggio","year":"2012","unstructured":"Piaggio G, Elbourne DR, Pocock SJ, Evans SJW, Altman DG. Reporting of noninferiority and equivalence randomized trials: extension of the CONSORT 2010 statement. JAMA. 2012;308(24):2594\u2013604.","journal-title":"JAMA"},{"issue":"Suppl 1","key":"296_CR19","doi-asserted-by":"publisher","first-page":"S108","DOI":"10.4103\/ijo.IJO_1827_19","volume":"68","author":"R Shukla","year":"2020","unstructured":"Shukla R, Murthy GVS, Gilbert C, Vidyadhar B, Mukpalkar S. Operational guidelines for retinopathy of prematurity in India: a summary. Indian J Ophthalmol. 2020;68(Suppl 1):S108\u201314.","journal-title":"Indian J Ophthalmol"},{"issue":"4","key":"296_CR20","doi-asserted-by":"publisher","first-page":"291","DOI":"10.1097\/ANC.0b013e318225a332","volume":"11","author":"AJ Mitchell","year":"2011","unstructured":"Mitchell AJ, Green A, Jeffs DA, Paula K, Roberson P. Physiologic effects of retinopathy of prematurity screening examinations. Adv Neonatal Care. 2011;11(4):291\u20137.","journal-title":"Adv Neonatal Care"},{"issue":"3","key":"296_CR21","doi-asserted-by":"publisher","first-page":"313","DOI":"10.1016\/j.ophtha.2022.10.016","volume":"130","author":"CB Hoppe","year":"2023","unstructured":"Hoppe CB, Yonamine S, Kao BW, et al. Randomized trial to evaluate the efficacy of the Nanodropper device for pupillary dilation and cycloplegia in children. Ophthalmology. 2023;130(3):313\u20139. https:\/\/doi.org\/10.1016\/j.ophtha.2022.10.016.","journal-title":"Ophthalmology"}],"container-title":["Maternal Health, Neonatology and Perinatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s40748-026-00296-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s40748-026-00296-1","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s40748-026-00296-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,7]],"date-time":"2026-09-07T22:03:09Z","timestamp":1788818589000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s40748-026-00296-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,9,8]]},"references-count":21,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["296"],"URL":"https:\/\/doi.org\/10.1186\/s40748-026-00296-1","relation":{},"ISSN":["2054-958X"],"issn-type":[{"value":"2054-958X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,9,8]]},"assertion":[{"value":"26 June 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 August 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 September 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The study protocol was approved by the Institutional Ethics Committee of Madras Medical College, Chennai (IEC No. MMC\/Approval\/12052025). The trial was registered with the Clinical Trials Registry of India (CTRI\/REF\/2025\/03\/101681) on 10-03-2025. Written informed consent was obtained from the parents or legal guardians prior to enrollment. The study was conducted in accordance with the Declaration of Helsinki.","order":1,"name":"Ethics","label":"Ethics approval and consent to participate","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","label":"Consent for publication","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":3,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Declarations"}}],"article-number":"49"}}